Accessibility Menu
 
Novartis Ag logo

Novartis Ag

(OTC) NVSEF

Current Price$150.19
Market Cap$286.59B
Since IPO (2003)+320%
5 Year+110%
1 Year+33%
1 Month-4%

Novartis Ag Financials at a Glance

Market Cap

$286.59B

Revenue (TTM)

$56.26B

Net Income (TTM)

$14.06B

EPS (TTM)

$7.16

P/E Ratio

20.84

Dividend

$4.74

Beta (Volatility)

0.10 (Low)

Price

$150.19

Volume

85

Open

$150.19

Previous Close

$150.19

Daily Range

$150.19 - $150.19

52-Week Range

$97.30 - $171.29

NVSEF News

No articles available.

NVSEF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novartis Ag

Industry

Pharmaceuticals

Employees

75,267

CEO

Vasant Narasimhan, MD

Headquarters

Basel, 4056, CH

NVSEF Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

31%

Net Income Margin

25%

Return on Equity

31%

Return on Capital

20%

Return on Assets

12%

Earnings Yield

4.80%

Dividend Yield

0.03%

Payout Ratio

53.54%

Stock Overview

Market Cap

$286.59B

Shares Outstanding

1.91B

Volume

85

Short Interest

0.00%

Avg. Volume

241.81K

Financials (TTM)

Gross Profit

$42.86B

Operating Income

$17.80B

EBITDA

$23.96B

Operating Cash Flow

$20.05B

Capital Expenditure

$1.62B

Free Cash Flow

$18.43B

Cash & ST Invst.

$11.58B

Total Debt

$37.01B

Novartis Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$13.44B

-0.8%

Gross Profit

$9.87B

-3.5%

Gross Margin

73.44%

N/A

Market Cap

$286.59B

N/A

Market Cap/Employee

$3.78M

N/A

Employees

75,883

N/A

Net Income

$2.43B

-13.8%

EBITDA

$6.21B

+19.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$25.43B

-42.0%

Accounts Receivable

$10.93B

+14.5%

Inventory

$6.26B

+9.7%

Long Term Debt

$31.23B

+36.2%

Short Term Debt

$5.78B

-30.5%

Return on Assets

12.13%

N/A

Return on Invested Capital

19.92%

N/A

Free Cash Flow

$1.52B

-50.2%

Operating Cash Flow

$2.15B

-48.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AZNCFAstraZeneca PLC
$189.90-1.35%
RHHBYRoche Holding AG
$48.11+1.53%
RHHBFRoche Holding AG
$397.80+5.87%
RHHVFRoche Holding AG
$403.29+8.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.95+0.07%
UGROUrban-gro
$6.15+1.82%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.57+0.03%
IBITiShares Bitcoin Trust
$40.05+0.01%

Questions About NVSEF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.